When Immune Youth Fuels Autoimmunity in Aging
A recently published Nature Aging review challenges the assumption that age-related immune decline is purely harmful. While older adults often lose defenses against infection and cancer, this decline may actually protect against autoimmunity. The authors argue that when the immune system retains too much “youthfulness,” it can backfire and fuel autoimmune disease in later life.
The authors use giant cell arteritis (GCA), an autoimmune vasculitis that only develops after age 50, as a model.
Immune aging in most older adults vs. giant cell arteritis (GCA)
In most older adults:
- T cells age and slow down → fewer new effector T cells are made.
- APCs add brakes → inhibitory signals help keep immune responses in check.
- Neoantigens → the slowed-down immune system largely ignores them.
- Result: immune decline leaves people more vulnerable to infections, but it also reduces the chance of autoimmunity.
In giant cell arteritis (GCA):
- TSCM cells stay unusually youthful → they keep producing aggressive effector T cells.
- APCs fail to provide brakes → inhibitory “stop signals” are missing.
- Neoantigens become targets → a “too young” immune system mistakes them for foreign invaders.
- Result: an overactive immune system attacks blood vessels, driving autoimmunity in older adults.
The broader takeaway is that immune aging may be an adaptive safeguard. Efforts to “rejuvenate” immunity in older adults could improve defenses against infection and cancer, but may also carry the unintended cost of increasing autoimmune disease risk.
Citation
Weyand, C. M., & Goronzy, J. J. (2025). Sustained immune youth risks autoimmune disease in the aging host. Nature aging, 5(8), 1404–1414. https://doi.org/10.1038/s43587-025-00919-w